Spire Healthcare Group has confirmed it has appointed Rothschild & Co to advise on a potential sale of the business. The London listed company, which reported EBITDA of £133.8m on revenue of £796.7m for the six months to 30 June 2025, said it was ‘actively working’ with its lead financial advisor to explore a range…
Join thousands of sector professionals

©2026 All rights reserved LaingBuisson

